FDA Import Refusal 799-0646345-8/11/2 — Eli Lilly Canada Inc.
The FDA refused shipment 799-0646345-8/11/2 from Eli Lilly Canada Inc. (Canada) on Mar 22, 2019. The refused product falls under Drugs and Biologics — INSULIN LISPRO PROTAMINE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 22, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PDL58 INSULIN LISPRO PROTAMINE (ANTI-DIABETIC)
- Charges
- 75